GPT and metabolic dysfunction-associated steatotic liver disease: This may explain the weaker association between eGFR and NAFLD in the population with ALT < 40 U/L and FPG > 6.1 mmol/L.Since these factors could modify the relationship between eGFR and NAFLD, it is clinically possible to reduce the risk of NAFLD by altering the strength of the association between the eGFR and NAFLD by interfering with HDL-c, ALT, DBP, and FPG levels.